Media

Hope Connections for Cancer is an amazing local charity whose mission is To help people with cancer and their loved ones deal with the emotional and physical impact of cancer

For the past 19 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with:  350 speakers, 1500 attendees and hundreds of networking opportunities. Back in 2015, we

AACR Annual Meeting 2020   The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical

About ASCO Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer. https://meetings.asco.org/immuno/registration-hotel?cmpid=db_immsym_rh_gadw_-_all_11-14-19_immsymhtml&cmpid=db_immsym_rh_srch_-_all_10-16-19_immsym

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members

Nov. 20, 2019 ROCKVILLE, MD – Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that Duane Mitchell, MD,

Poster Title: Lysosomal-associated membrane protein-1-targeting of a poly-neoepitope DNA vaccine elicits potent immune responses and inhibits tumor growth by Dr. Pratima Sinha, Ph.D. Presentation Date: Saturday, November 9th 7:00 am

Poster Title: Functional evaluation of isoforms present in pDNA vaccines Poster Session Date: Tuesday, November 6, 2018 Location: Aldevron, Fargo ND   Download poster here.

November 04, 2019 08:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, today announced that

Poster Title: Lysosomal-associated membrane protein-1-targeting of the large T antigen of Merkel cell polyomavirus elicits potent CD4+ T cell responses Poster Session Date and Time: Monday, October 21, 2019 11:15

Data demonstrates that UNITE, as a nucleic acid platform, elicits potent immune responses ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. will present data on its investigational nucleic acid platform, UNITE (UNiversal

Discussion of UNITE platform as applied in cancer immunotherapy BOSTON--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. announced today a presentation at the Precision Lung Cancer World R&D Summit in Boston. On Tuesday,